KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Petmed Express (PETS) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Petmed Express (PETS) over the last 17 years, with Q3 2025 value amounting to -$231000.0.

  • Petmed Express' Cash from Financing Activities fell 22535.21% to -$231000.0 in Q3 2025 from the same period last year, while for Dec 2025 it was -$266000.0, marking a year-over-year decrease of 3711.34%. This contributed to the annual value of -$181000.0 for FY2025, which is 9854.47% up from last year.
  • Per Petmed Express' latest filing, its Cash from Financing Activities stood at -$231000.0 for Q3 2025, which was down 22535.21% from -$30000.0 recorded in Q2 2025.
  • Petmed Express' 5-year Cash from Financing Activities high stood at -$1000.0 for Q4 2024, and its period low was -$6.3 million during Q3 2023.
  • Its 5-year average for Cash from Financing Activities is -$3.5 million, with a median of -$6.0 million in 2021.
  • As far as peak fluctuations go, Petmed Express' Cash from Financing Activities surged by 9975.39% in 2023, and later tumbled by 22535.21% in 2025.
  • Over the past 5 years, Petmed Express' Cash from Financing Activities (Quarter) stood at -$6.1 million in 2021, then decreased by 0.54% to -$6.1 million in 2022, then surged by 99.75% to -$15000.0 in 2023, then surged by 93.33% to -$1000.0 in 2024, then tumbled by 23000.0% to -$231000.0 in 2025.
  • Its Cash from Financing Activities stands at -$231000.0 for Q3 2025, versus -$30000.0 for Q2 2025 and -$5000.0 for Q1 2025.